IL-33-Induced Cytokine Secretion and Survival of Mouse Eosinophils Is Promoted by Autocrine GM-CSF.
Eosinophils are major effector cells during allergic responses and helminth infections. Recent studies further highlight eosinophils as important players in many other biological processes. Therefore it is important to understand how these cells can be modulated in terms of survival and effector function. In the present study we investigated how eosinophils respond to the alarmin IL-33. We show that IL-33 promotes eosinophil survival in a ST2- and MyD88-dependent manner. IL-33-mediated protection from apoptosis was dependent on autocrine GM-CSF release. In addition, GM-CSF increased the IL-33-induced secretion of IL-4 and IL-13 from eosinophils. Unexpectedly, this effect was further enhanced by cross-linking of Siglec-F, a proposed inhibitory and apopotosis-inducing receptor on eosinophils. Co-culture experiments with eosinophils and macrophages revealed that the IL-33-induced release of IL-4 and IL-13 from eosinophils was required for differentiation of alternatively activated macrophages (AAMs). The differentiation of AAMs could be further increased in the presence of GM-CSF. These results indicate that cross-talk between Siglec-F and the receptors for IL-33, LPS and GM-CSF plays an important role for efficient secretion of IL-4 and IL-13. Deciphering the molecular details of this cross-talk could lead to the development of new therapeutic option to treat eosinophil-associated diseases.
Department of Infection Biology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
Ralf
R
Willebrand
Department of Infection Biology, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
David
D
Voehringer
Proc Natl Acad Sci U S A. 2012 Feb 28;109(9):3451-6
22331917
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9914-9
23716700
Immunol Lett. 2014 Jul;160(1):11-6
24698729
J Exp Med. 1994 Aug 1;180(2):711-5
8046346
Nat Rev Immunol. 2014 Oct;14(10):653-66
25234143
Cell. 2013 Apr 11;153(2):376-88
23582327
J Exp Med. 1999 May 17;189(10):1565-72
10330435
Immunity. 2015 Jul 21;43(1):161-74
26092469
Cytokine. 2012 Jan;57(1):169-74
22079334
Allergy. 2015 Sep;70(9):1148-59
26009788
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):282-7
23248269
J Allergy Clin Immunol. 2013 Sep;132(3):704-712.e10
23683462
J Immunol. 2009 Nov 1;183(9):5600-7
19843944
J Allergy Clin Immunol. 2008 Jun;121(6):1484-90
18539196
J Leukoc Biol. 2007 Jun;81(6):1434-44
17339609
Am J Respir Cell Mol Biol. 2000 Dec;23(6):780-7
11104731
Immunity. 1998 Jul;9(1):143-50
9697844
Blood. 2010 Oct 28;116(17):3311-20
20625006
Allergy. 2008 Sep;63(9):1156-63
18699932
Allergy. 2014 Jun;69(6):719-29
24735452
J Immunol. 2010 Sep 15;185(6):3472-80
20693421
Blood. 1998 Aug 1;92 (3):778-83
9680344
J Immunol. 2009 Nov 15;183(10 ):6469-77
19841166
J Immunol. 2000 Aug 15;165(4):1965-75
10925279
Immunity. 2015 Jul 21;43(1):187-99
26200014
J Immunol. 2009 Oct 15;183(8):5333-41
19783675
J Immunol. 2007 Oct 1;179(7):4766-74
17878375
Immunity. 2005 Nov;23 (5):479-90
16286016
J Immunol. 2004 Sep 1;173(5):2918-22
15322148
Lab Invest. 2008 Nov;88(11):1245-53
18762778
Blood. 2015 Jun 18;125(25):3896-904
25862560
J Immunol. 2013 Oct 15;191(8):4317-25
24043894
Blood. 2008 Jun 15;111(12):5694-703
18316626
Nature. 2015 Mar 12;519(7542):242-6
25533952
Eur J Immunol. 2015 Mar;45(3):876-85
25504587
J Exp Med. 1999 Nov 15;190(10 ):1541-8
10562328
Science. 2011 Apr 8;332(6026):243-7
21436399
Blood. 2007 May 15;109(10):4280-7
17272508
EMBO J. 2015 Jan 13;34(2):218-35
25398911
J Cell Death. 2014 Feb 10;7:1-9
25278781
J Immunol. 2005 Jan 15;174(2):1063-72
15634931
Immunol Lett. 2015 Mar;164(1):11-7
25662624
J Immunol. 2008 Sep 15;181(6):4004-9
18768855
Immunity. 2015 Jun 16;42(6):1005-19
26084021